英国临床瘤学学术培训的前景:全国跨部门分析
C M Jones1, W H Ng2, K Spencer3
1Department of Oncology, University of Cambridge, Cambridge, UK; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Clinical oncology (Royal College of Radiologists (Great Britain))
|August 30, 2024
概括
英国的临床瘤学学术培训面临重大障碍,包括有限的研究技能和进展挑战. 改善指导和培训计划对于促进临床学术界的研究独立性至关重要.
科学领域:
- 在瘤学瘤学.
- 医学教育 医学教育
- 研究 培训 培训 培训
背景情况:
- 临床学术培训管道对于医学进步至关重要,但面临着持续的障碍.
- 以前的证据强调了影响临床学术界职业发展的多个因素.
研究的目的:
- 评估英国临床瘤学学术培训的具体障碍和推动因素.
- 评估这些因素在英国临床瘤学实习生和顾问中的程度.
主要方法:
- 在2013年至2024年间接受过学术职位的临床瘤学实习生和顾问中分发了一份横截面的在线调查.
- 该调查收集了有关人口统计,培训阶段,研究经验,技能信心和职业发展的数据.
主要成果:
- 分析了70个回复,占英国培训院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长院长
- 确定的主要障碍包括临床培训需求,有限的职位可用性和缺乏指导.
- 大多数人对放射性瘤学研究技能缺乏信心,这影响了研究独立的进展.
结论:
- 英国的学术临床瘤学培训表明,研究独立的进展很差.
- 对放射性瘤学研究技能的信心有限,以及多种职业障碍阻碍了学术发展.
- 为决策者,资助者和培训计划提供建议,以加强临床瘤学学术培训.
相关概念视频
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K